Oriola-KD Corporation's Interim Report for 1 January – 30 June 2012

Posted: Published on July 26th, 2012

This post was added by Dr P. Richardson

Oriola-KD Corporation Stock Exchange Release 26 July 2012 at 8.30 a.m.

Key figures for 1 January - 30 June 2012

Net sales increased by 10.8 per cent to EUR 1,180.6 million (1-6/2011: EUR 1,065.6 million).

Operating profit was EUR 9.7 million (1-6/2011: operating loss EUR 29.4 million including an EUR 33.4 million impairment charge related to the Russian Stary Lekar brand and operating profit excluding impairment charge EUR 4.0 million).

Net cash flow from operations was EUR -8.1 million (1-6/2011: EUR -16.1 million).

Net profit was EUR 3.2 million (1-6/2011: EUR -27.5 million) and earnings per share were EUR 0.02 (1-6/2011: EUR -0.18).

Return on equity was 2.2 per cent (1-6/2011: -16.8 per cent).

Outlook for 2012 is unchanged: Oriola-KD`s net sales are expected to increase 10-15 per cent and operating profit excluding one-off items is expected to come to EUR 23-33 million in 2012.

Key figures for 1 April - 30 June 2012

Net sales increased by 10.1 per cent to EUR 589.7 million (4-6/2011: EUR 535.5 million).

Read this article:
Oriola-KD Corporation's Interim Report for 1 January - 30 June 2012

Related Posts
This entry was posted in Wholesale Pharmacy. Bookmark the permalink.

Comments are closed.